about
Molecular markers of endometrial carcinoma detected in uterine aspirates.Exosome-like vesicles in uterine aspirates: a comparison of ultracentrifugation-based isolation protocols.Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples.Total laparoscopic radical hysterectomy for cervical cancer in prolapsed uterus.The EMT signaling pathways in endometrial carcinoma.MicroRNAs as prognostic markers in ovarian cancer.Analysis of gene expression regulated by the ETV5 transcription factor in OV90 ovarian cancer cells identifies FOXM1 overexpression in ovarian cancer.Vulvar intraepithelial neoplasia: clinical presentation, management and outcomes in women infected with HIV.Generation and characterization of orthotopic murine models for endometrial cancer.Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion.Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis.Molecular diagnosis of endometrial cancer from uterine aspirates.Advances in endometrial cancer protein biomarkers for use in the clinic.Targeted Proteomics Identifies Proteomic Signatures in Liquid Biopsies of the Endometrium to Diagnose Endometrial Cancer and Assist in the Prediction of the Optimal Surgical Treatment.Change in clinical management of sentinel lymph node location in early stage cervical cancer: the role of SPECT/CT.Comparison of robotic-assisted vs conventional laparoscopy for extraperitoneal paraaortic lymphadenectomy.Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.Location of aortic node metastases in locally advanced cervical cancer.Prospective Randomized Trial Comparing Transperitoneal Versus Extraperitoneal Laparoscopic Aortic Lymphadenectomy for Surgical Staging of Endometrial and Ovarian Cancer: The STELLA Trial.Preaortic left primitive iliac veinPatient-Derived Xenograft Models for Endometrial Cancer ResearchMucocele of the appendixMicrometastases in para-aortic lymph nodes in advanced cervical cancer patients--are a true predictor of recurrence at this level?Extraperitoneal laparoscopic approach for diagnosis and treatment of aortic lymph node recurrence in gynecologic malignancyPretherapeutic extraperitoneal laparoscopic staging of bulky or locally advanced cervical cancerPathology findings and clinical outcomes after risk reduction salpingo-oophorectomy in BRCA mutation carriers: a multicenter Spanish studyLaparoscopic Extraperitoneal Pelvic Lymph Node Debulking in Locally Advanced Cervical CancerEvaluation of the intraoperative human papillomavirus test as a marker of early cure at 12 months after electrosurgical excision procedure in women with cervical high-grade squamous intraepithelial lesion: a prospective cohort studyVaginal Intraepithelial Neoplasia: Clinical Presentation, Management, and Outcomes in Relation to HIV Infection StatusTherapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancerA giant superinfected uterine angioleiomyoma with distant septic metastases: an extremely rare presentation of a benign process and a systematic review of the literatureTechnetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer
P50
Q34157607-065CBD77-7C7B-4965-B697-FC19ED9D774DQ37018155-F06BA8A5-C2ED-4F61-AFB1-A6D17F11EF51Q37619708-22F0C2EF-711C-49BB-82FA-C8919600F225Q37734288-6E522A98-89B4-4F6B-B6BE-9AF6DC8E37EEQ38036605-F69B59F6-6BC2-4069-9DF8-867867B10649Q38205688-34F0417D-C8B0-4DC2-99B8-3533B9B32387Q38325265-54A6621A-2491-49C4-81C2-01FD1A3EA3C7Q38766939-95220B2E-0F11-4477-9DDC-52D3D8E9E1F0Q39422372-9393DA58-2466-4AB4-8B73-93876CC7AD7FQ40997717-251C1BBD-5BDD-4F6D-9613-A41B23996941Q41459821-4E1B3885-DDE4-4DB1-A71A-6083728AAD01Q44593249-D67E6BF3-B531-430D-B081-41D83332E7B3Q47355920-878C0C68-7ABE-46FA-8BF5-4849B5D748DAQ47733361-DF7E107B-4A88-4636-BA9A-8D1FA0DD98CEQ50438924-6806D559-8EDA-464E-BD1F-21FEE79CA348Q51141494-25BDDC75-CB0E-4092-9128-DC67364A82F1Q51311386-B3EEE76B-5733-478C-88FD-F9E52F177A8AQ51423324-14262CD9-4112-4C3A-9394-C4F1AF0DB94FQ53118309-A6DDFA7A-FE79-4D12-B8B2-05A337091D56Q57643984-D4A618B2-4402-4F55-8596-6A08CDFFADD8Q58768056-4B0F1EF1-AA22-4784-B530-D35929AD51B2Q80803522-717914B1-963B-41F0-8112-DB45B700752DQ83056056-34951747-D943-4A3A-B5F9-DE243E59332FQ84482088-A2E8C1D4-3A11-44FA-82B9-07AEDE918006Q85026141-5A1AE7CC-ADBE-4262-B747-2C6C8CFF1FFEQ88288900-EDD8AE19-6FA4-4045-9299-E8482C77A16CQ88758363-BF3F8F1D-18A8-47B6-BF70-0A3F3DE6DD62Q90012118-486DB0DE-BE92-4914-AC77-1C03960E439CQ91222735-FCFEF3DC-2706-4FD2-A9E1-5A81B1FF9902Q92252183-27F18499-ACDB-4ACE-A1A3-43DF504A89DAQ92762998-0EFDAA78-B0CF-4816-975F-5962ED63F8E6Q93011423-87684E8A-777B-48CA-91CA-2129CF19D158
P50
description
researcher ORCID ID = 0000-0002-3164-6686
@en
wetenschapper
@nl
name
Silvia Cabrera
@ast
Silvia Cabrera
@en
Silvia Cabrera
@es
Silvia Cabrera
@nl
type
label
Silvia Cabrera
@ast
Silvia Cabrera
@en
Silvia Cabrera
@es
Silvia Cabrera
@nl
prefLabel
Silvia Cabrera
@ast
Silvia Cabrera
@en
Silvia Cabrera
@es
Silvia Cabrera
@nl
P106
P1153
36127338400
P21
P31
P496
0000-0002-3164-6686